BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 12594846)

  • 21. Role of MHC class II expressing CD4+ T cells in proteolipid protein(91-110)-induced EAE in HLA-DR3 transgenic mice.
    Mangalam A; Rodriguez M; David C
    Eur J Immunol; 2006 Dec; 36(12):3356-70. PubMed ID: 17125142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 320-kilobase artificial chromosome encoding the human HLA DR3-DQ2 MHC haplotype confers HLA restriction in transgenic mice.
    Chen Z; Dudek N; Wijburg O; Strugnell R; Brown L; Deliyannis G; Jackson D; Koentgen F; Gordon T; McCluskey J
    J Immunol; 2002 Mar; 168(6):3050-6. PubMed ID: 11884478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of HLA DR3/DQ2 transgenic mice: a potential humanized animal model for autoimmune disease studies.
    Chen D; Ueda R; Harding F; Patil N; Mao Y; Kurahara C; Platenburg G; Huang M
    Eur J Immunol; 2003 Jan; 33(1):172-82. PubMed ID: 12594846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA class II transgenic mice mimic human inflammatory diseases.
    Mangalam AK; Rajagopalan G; Taneja V; David CS
    Adv Immunol; 2008; 97():65-147. PubMed ID: 18501769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA transgenic mice as models of human autoimmune diseases.
    Das P; Abraham R; David C
    Rev Immunogenet; 2000; 2(1):105-14. PubMed ID: 11324683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiology of autoimmune diseases.
    Boitard C
    Klin Wochenschr; 1990; 68 Suppl 21():1-9. PubMed ID: 1973964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA transgenic mice as humanized mouse models of disease and immunity.
    Taneja V; David CS
    J Clin Invest; 1998 Mar; 101(5):921-6. PubMed ID: 9486959
    [No Abstract]   [Full Text] [Related]  

  • 28. Modification of cytokine patterns in subjects bearing the HLA-B8,DR3 phenotype: implications for autoimmunity.
    Lio D; Candore G; Romano GC; D'Anna C; Gervasi F; Di Lorenzo G; Modica MA; Potestio M; Caruso C
    Cytokines Cell Mol Ther; 1997 Dec; 3(4):217-24. PubMed ID: 9740350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of genetic factors in organ-specific autoimmune diseases induced by manipulating the thymus or T cells, and not self-antigens.
    Sakaguchi S; Sakaguchi N
    Rev Immunogenet; 2000; 2(1):147-53. PubMed ID: 11324687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA and H2 class II transgenic mouse models to study susceptibility and protection in autoimmune thyroid disease.
    Kong YC; Flynn JC; Wan Q; David CS
    Autoimmunity; 2003; 36(6-7):397-404. PubMed ID: 14669947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA class II transgenic mice as models of human diseases.
    Taneja V; David CS
    Immunol Rev; 1999 Jun; 169():67-79. PubMed ID: 10450509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?).
    Wagner DH
    Clin Exp Immunol; 2016 Sep; 185(3):271-80. PubMed ID: 27271348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic control of immune response and disease susceptibility by the HLA-DQ gene.
    Nishimura Y; Kamikawaji N; Fujisawa K; Yoshizumi H; Yasunami M; Kimura A; Sasazuki T
    Res Immunol; 1991; 142(5-6):459-66. PubMed ID: 1684444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is the basis for HLA-DQ associations with autoimmune disease?
    Altmann DM; Sansom D; Marsh SG
    Immunol Today; 1991 Aug; 12(8):267-70. PubMed ID: 1910448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA class II transgenic mice: models of the human CD4+ T-cell immune response.
    Sønderstrup G; Cope AP; Patel S; Congia M; Hain N; Hall FC; Parry SL; Fugger LH; Michie S; McDevitt HO
    Immunol Rev; 1999 Dec; 172():335-43. PubMed ID: 10631958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenesis of multiple sclerosis.
    Ffrench-Constant C
    Lancet; 1994 Jan; 343(8892):271-5. PubMed ID: 7905102
    [No Abstract]   [Full Text] [Related]  

  • 37. Allelic exclusion and lymphocyte development. Lessons from transgenic mice.
    Rimm IJ; Bloch DB; Seidman JG
    Mol Biol Med; 1989 Aug; 6(4):355-64. PubMed ID: 2560118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Role of Human Leukocyte Antigen in Health and Disease.
    Mosaad YM
    Scand J Immunol; 2015 Oct; 82(4):283-306. PubMed ID: 26099424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transgenic mice models in autoimmunity--discussion.
    Rink L; Wenzel BE
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 3():46-8. PubMed ID: 8986423
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.